Referral for 'prostatism': Developing a 'performance indicator' for the threshold between primary and secondary care?

Family Practice

Volumn 16, Issue 2, 1999, Pages 140-142

  Elwyn, Glyn Jones ^a   Rix, Andrew ^a,b   Matthews, Philip ^b   Stott, Nigel Ch ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Performance indicator; Prostatism

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; CLINICAL PRACTICE; HOSPITAL MANAGEMENT; HUMAN; MALE; MEDICAL RECORD; MEDICAL SPECIALIST; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PROSTATISM; RECTUM DISEASE; RESIDUAL URINE; TEACHING HOSPITAL; UNITED KINGDOM; URINE FLOW RATE; UROLOGY;

FAMILY PRACTICE; HUMANS; MALE; PRIMARY HEALTH CARE; PROSTATIC HYPERPLASIA; QUALITY INDICATORS, HEALTH CARE; REFERRAL AND CONSULTATION; UROLOGY; WALES;

EID: 0033025806     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/16.2.140     Document Type: Article

References (23)

1. Oldham J. An inspectorate for the health service? Br MedJ 1997; 315:896-897.
2. Roland M, Coulter A (eds). Hospital Referrals. Oxford General Practice Series, Vol. 22. Oxford: Oxford University Press, 1992.
3. Wilkin D, Smith A. Explaining variation in general practitioner referrals to hospital. Fam Pract 1987; 4:160-169.
4. Anderson TF, Mooney G (eds). The Challenge of Medical Practice Variation. London: Macmillan, 1996.
5. Fertig A, Roland M, King H, Moore T. Understanding variation in rates of referral among general practitioners: are inappropriate referrals important and would guidelines help to reduce rates? Br MedJ 1993; 307:1467-1470.
6. Hicks NR. Some observations on attempts to measure the appropriateness of care. Br MedJ 1994; 309:730-733.
7. Phelps CE. The methodologie foundations of studies of the appropriateness of medical care. N EnglJ Med 1993; 329:1241-1245.
8. Brook RH. Appropriateness: the next frontier. Br MedJ 1994; 308: 217-218.
9. Cummins R, Jarman B, White P. Do general practitioners have different referral thresholds? Br MedJ 1981; 282:1037-1039.
10. NHS Centre for Reviews and Dissemination. Benign Prostatic Hyperplasia. Effective Health Care Bulletin 1995; 2(2).
11. NHS Centre for Reviews and Dissemination. Screening for Prostate Cancer. Effectiveness Matters 1997; 2(2).
12. Elwyn GJ, Stott NCH. Avoidable referrals? Analysis of 170 consecutive referrals to secondary care. Br Med J 1994; 309: 576-579.
13. Wagner EH, Barrett P, Barry MJ, Barlow W, Fowler FJ. The effect of a shared decision-making program on rates of surgery for benign prostatic hyperplasia. Med Care 1995; 33:765-770.
14. Sheppard S, Coulter A, Farmer A. Using interactive videos in general practice to inform patients about treatment choices: a pilot study. Fam Pract 1995; 12:443-448.
15. Chamberlain J, Melia J, Moss S, Brown J. The diagnosis, management, treatment and costs of prostate cancer in England and Wales. Health Technology Assessment 1997; 1(2).
16. Warner MM. Health Strategy for the 1990s: Five Areas for Substitution. Health Care UK. London: King's Fund Institute, 1991.
17. Woolf SH. Screening for prostate cancer with prostate specific antigen: an examination of the evidence. N Engl J Med 1995; 333:1401-1405.
18. Woolf SH. Should we screen for prostate cancer? Br MedJ 1997; 314:989-991.
19. Walsh PC. Using prostate specific antigen to diagnose prostate cancer: sailing in uncharted waters. Ann Int Med 1993; 119(9): 948-949.
20. Wolf AMD, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 1996; 156:1333-1336.
21. Ham C. Primary Managed Care in Europe. Br MedJ 1997; 314:457.
22. GMSC Core Services: Taking the Initiative. London: GMSC, 1996.
23. Elwyn GJ, Jones S, Edwards P. "Appropriateness of referral to urologists"-can it be defined for symptoms of benign prostatic obstruction and used as a quality measure? Br J Urol 1999; in press.